Fludarabine as second line therapy for B-cell chronic lymphocytic leukaemia: Effectiveness annexe
The report attempts to assess whether fludarabine has greater effects on patients with CLL than other commonly used treatments.
|
Fludarabine as second line therapy for B-cell chronic lymphocytic leukaemia: Effectiveness annexe
25 September 2001 (126.34 Kb 36 sec) |
This page was last updated: 30 March 2010